Cargando…
Prenatal Pharmacogenomics: A promising area for research
Clinical applications of prenatal genetic screening currently focus on detection of aneuploidy and other genetic diseases in the developing fetus. Growing evidence suggests that the fetal genome may also be informative about fetal exposures, through contributions to placental transport as well as pl...
Autores principales: | Dorfman, Elizabeth H., Cheng, Edith Y., Hebert, Mary F., Thummel, Kenneth E., Burke, Wylie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956529/ https://www.ncbi.nlm.nih.gov/pubmed/27168097 http://dx.doi.org/10.1038/tpj.2016.33 |
Ejemplares similares
-
Pharmacogenomics: the promise of personalized medicine.
por: Hood, Ernie
Publicado: (2003) -
Pharmacogenomic testing and antidepressant response: problems and promises
por: Smith, Tawny L., et al.
Publicado: (2020) -
Developing a Prototype System for Integrating Pharmacogenomics Findings into Clinical Practice
por: Overby, Casey Lynnette, et al.
Publicado: (2012) -
User considerations in assessing pharmacogenomic tests and their clinical support tools
por: Mukerjee, Gouri, et al.
Publicado: (2018) -
Editorial: The role of pharmacogenomics in addressing health disparities: the path, the promise, and the barriers
por: Roman, Youssef M.
Publicado: (2023)